VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX)
CUSIP: 92532F100
Q4 2019 13F Holders as of 31 Dec 2019
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 254,691,824
- Total 13F shares
- 243,469,587
- Share change
- -2,548,947
- Total reported value
- $53,307,090,832
- Put/Call ratio
- 100%
- Price per share
- $218.95
- Number of holders
- 801
- Value change
- -$548,123,974
- Number of buys
- 386
- Number of sells
- 298
Quarterly Holders Quick Answers
What is CUSIP 92532F100?
CUSIP 92532F100 identifies VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92532F100:
Top shareholders of VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
10%
|
26,290,113
|
$4,454,071,000 | — | 30 Sep 2019 | |
| FMR LLC |
13F
|
Company |
9.7%
|
24,732,014
|
$4,190,097,000 | — | 30 Sep 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
8.3%
|
21,074,121
|
$3,570,375,000 | — | 30 Sep 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.8%
|
19,928,179
|
$3,376,232,000 | — | 30 Sep 2019 | |
| STATE STREET CORP |
13F
|
Company |
4.4%
|
11,313,608
|
$1,916,751,000 | — | 30 Sep 2019 | |
| Capital World Investors |
13F
|
Company |
4.2%
|
10,586,833
|
$1,793,620,000 | — | 30 Sep 2019 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.2%
|
8,243,547
|
$1,396,624,000 | — | 30 Sep 2019 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
2.3%
|
5,977,741
|
$1,012,749,000 | — | 30 Sep 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.3%
|
5,799,117
|
$982,486,000 | — | 30 Sep 2019 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
2.3%
|
5,781,215
|
$979,453,000 | — | 30 Sep 2019 | |
| Clearbridge Investments, LLC |
13F
|
Company |
2%
|
5,015,885
|
$849,791,000 | — | 30 Sep 2019 | |
| Invesco Ltd. |
13F
|
Company |
1.4%
|
3,659,931
|
$620,066,000 | — | 30 Sep 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
3,457,078
|
$584,679,000 | — | 30 Sep 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.3%
|
3,373,814
|
$571,590,000 | — | 30 Sep 2019 | |
| Capital International Investors |
13F
|
Company |
1.2%
|
3,023,390
|
$512,223,000 | — | 30 Sep 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
2,952,220
|
$500,164,000 | — | 30 Sep 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1%
|
2,581,594
|
$437,375,000 | — | 30 Sep 2019 | |
| NORGES BANK |
13F
|
Company |
0.94%
|
2,382,379
|
$403,623,000 | — | 30 Sep 2019 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.93%
|
2,378,766
|
$402,981,000 | — | 30 Sep 2019 | |
| HARDING LOEVNER LP |
13F
|
Company |
0.91%
|
2,323,082
|
$393,576,000 | — | 30 Sep 2019 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
0.88%
|
2,239,474
|
$379,412,000 | — | 30 Sep 2019 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.81%
|
2,067,251
|
$350,233,000 | — | 30 Sep 2019 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.74%
|
1,872,267
|
$317,199,000 | — | 30 Sep 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.63%
|
1,609,339
|
$272,653,000 | — | 30 Sep 2019 | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main |
13F
|
Company |
0.59%
|
1,504,824
|
$254,947,000 | — | 30 Sep 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.58%
|
1,479,735
|
$250,691,000 | — | 30 Sep 2019 | |
| Legal & General Group Plc |
13F
|
Company |
0.57%
|
1,462,915
|
$247,855,000 | — | 30 Sep 2019 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.57%
|
1,460,279
|
$247,237,000 | — | 30 Sep 2019 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.56%
|
1,433,588
|
$242,878,000 | — | 30 Sep 2019 | |
| Bellevue Group AG |
13F
|
Company |
0.56%
|
1,429,139
|
$242,125,000 | — | 30 Sep 2019 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.54%
|
1,384,893
|
$234,628,572 | — | 30 Sep 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.54%
|
1,370,387
|
$232,172,000 | — | 30 Sep 2019 | |
| Capital Research Global Investors |
13F
|
Company |
0.49%
|
1,250,270
|
$211,821,000 | — | 30 Sep 2019 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.49%
|
1,247,868
|
$211,414,000 | — | 30 Sep 2019 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.49%
|
1,241,319
|
$210,304,000 | — | 30 Sep 2019 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.48%
|
1,221,424
|
$206,934,000 | — | 30 Sep 2019 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.48%
|
1,219,940
|
$206,682,000 | — | 30 Sep 2019 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.46%
|
1,169,844
|
$198,195,000 | — | 30 Sep 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.44%
|
1,109,026
|
$187,892,000 | — | 30 Sep 2019 | |
| EATON VANCE MANAGEMENT |
13F
|
Company |
0.42%
|
1,064,392
|
$180,329,000 | — | 30 Sep 2019 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.41%
|
1,048,055
|
$177,562,000 | — | 30 Sep 2019 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.39%
|
989,877
|
$167,705,000 | — | 30 Sep 2019 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
0.37%
|
932,748
|
$158,026,000 | — | 30 Sep 2019 | |
| S.c.a. Candriam |
13F
|
Individual |
0.37%
|
930,999
|
$157,730,000 | — | 30 Sep 2019 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.35%
|
903,612
|
$153,090,000 | — | 30 Sep 2019 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.34%
|
872,501
|
$147,819,000 | — | 30 Sep 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.34%
|
871,356
|
$147,624,000 | — | 30 Sep 2019 | |
| Swiss National Bank |
13F
|
Company |
0.34%
|
864,975
|
$146,544,000 | — | 30 Sep 2019 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.33%
|
846,400
|
$143,397,000 | — | 30 Sep 2019 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.31%
|
777,293
|
$131,689,000 | — | 30 Sep 2019 |
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q4 2019
As of 31 Dec 2019,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
801 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
243,469,587 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Capital World Investors, WELLINGTON MANAGEMENT GROUP LLP, RENAISSANCE TECHNOLOGIES LLC, ALLIANCEBERNSTEIN L.P., and Capital International Investors.
This page lists
802
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2019 vs Q3 2019 Across Filers
Q3 2019 holders
696
Q4 2019 holders
801
Holder diff
105
| Investor | Q3 2019 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q3 2019 Value $ | Q4 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.